SCHEMBL21230145

SCHEMBL21230145

Nc1ccc(C(=O)N2CCN(CC3CCCC3)CC2)cc1OC(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 5/20 0.47
▸ PDE4B Q07343 5/20 0.47
▸ PDE4C Q08493 5/20 0.47
▸ PDE4D Q08499 5/20 0.47
▸ NAMPT P43490 1/20 0.45
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ PRKAA2 P54646 1/20 0.40
▸ S1PR2 O95136 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LRRK2 Q5S007 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ACHE P22303 2/20 0.39
▸ HTR4 Q13639 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753660 0.85 HTR4 (0.50) NAMPTKMT2AALDH1A1ACHEHTR4
SCHEMBL20073407 0.83 HPGD (0.47) MEN1KMT2AALDH1A1LRRK2KDM4E
SCHEMBL13880931 0.81 HTR4 (0.52) MEN1KMT2AALDH1A1KDM4EHTR4
SCHEMBL15650740 0.81 HSP90AA1 (0.46) PDE4APDE4BPDE4CPDE4DNAMPT
SCHEMBL20750534 0.81 KDM4E (0.44) MEN1KMT2AALDH1A1LRRK2KDM4E
SCHEMBL16982497 0.79 KMT2A (0.53) MEN1KMT2AALDH1A1LRRK2KDM4E
SCHEMBL20750393 0.79 KDM4E (0.40) MEN1KMT2AALDH1A1KDM4EHTR4
SCHEMBL20750380 0.77 SIGMAR1 (0.46) KDM4ELMNAGLAHTTRAB9A
SCHEMBL17076877 0.77 LRRK2 (0.51) KMT2ALRRK2KDM4EGLAPOLB
SCHEMBL20036180 0.75 NAMPT (0.60) NAMPTKMT2APRKAA2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2704720-B1 PYRUVATE KINASE R ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS INC (US) 2019-08-07 — — EP disclosed
Send feedback